FDA Funding For Drug Ad Reviews Faces Debate
The Food and Drug Administration may soon have more money to investigate claims made in drug ads, but the source of that money will likely face a spirited debate in Congress....To view the full article, register now.
Already a subscriber? Click here to view full article